@lcrf.orgEvery #WomenWednesday, we are spotlighting women who are making a difference in the lung cancer community – in labs, at hospitals, and by sharing their stories.
Nadia tells about the women she lost to #LungCancer – and why she champions research for all the parients who deserve more time.
@lcrf.orgThe World Conference on Lung Cancer is the world’s largest multidisciplinary meeting dedicated to thoracic malignancies – and we'll be talking about the news from the event at our October 7 Together Separately livestream. Learn more and RSVP at lcrf.org/together. #LungCancer #WCLC26
@thecancersurvivorsclub.comEncouraging progress in lung cancer. New antibody-drug conjugates showed significant survival benefits in small cell lung cancer, while Enhertu delivered promising results in HER2-positive disease.
@lcrf.org#ICYMI - The FDA has granted accelerated approval of sevebertinib as a first treatment option for HER2+ #LungCancer, offering patients a targeted oral therapy earlier than before. buff.ly/iSHA0qn
@trackerbiobank.bsky.social🌏 That’s a wrap on #WCLC2026!
Congratulations to Dr Stephen Wong on a fantastic poster, highlighting methylation differences between immunotherapy responders and non-responders and potential biomarkers of treatment response and resistance in lung cancer. 👏
@nealaugenstein.bsky.socialI'm excited/nervous to describe 'My life with #lungcancer' to open this great conference, in less than a month. I'll be speaking to researchers & leading oncologists (including my own, who've helped keep me cancer-free since 2023, 5 months after being diagnosed w stage 4.)
@lungcancereurope.bsky.socialThe science has moved. Now Europe must.
#WCLC26 brought advances that could change #lungcancer care. The next job is turning evidence into approval, implementation and equitable access across Europe.
Our week in Seoul: lungcancereurope.eu/news/lung-ca...
@go2forlungcancer.bsky.socialWe presented 10 #LungCancer research studies at the IASLC 2026 World Conference on Lung Cancer.
Our research explored real-world barriers to screening, biomarker testing, clinical trial access, health literacy, & support.
Read more about #WCLC26: tinyurl.com/25eu5zex
@cancertherapyadv.bsky.socialAmbient air pollution has been associated with poorer 5-year survival with #LungCancer 🫁
Survival varies differently across populations; non-smokers may be more vulnerable to the effects of pollution.
Read all the data on this #WCLC26 presentation here: https://bit.ly/4hsmwzo
@lancetrespirmed.bsky.social🎙️ New Podcast: The changing treatment landscape in #LungCancer
Solange Peters, Lizza Hendriks, and Martin Reck join Jonathan Blott to discuss our new joint Series with The Lancet on therapeutics in lung cancer, launched at #ERS2026.
@lcrf.orgPresenting today at the World Conference on Lung Cancer: LCRF grantee Dr. Xiuning Le from @mdanderson.bsky.social. Her research addresses an important question: why do some cancers eventually begin growing again despite treatment?
Read more at LCRF.org/LeResearch
@eaonc.bsky.socialThe EA5221/ACHIEVE clinical study is testing two different treatment approaches for older adults with advanced non-small cell #LungCancer. Learn more: https://bit.ly/ea5221-achieve #NSCLC #LCSM
@nciartnet.orgNew research identifies TNIK as a potential driver of chemoradiation resistance in limited-stage small cell lung cancer (SCLC).
🔗 pubmed.ncbi.nlm.nih.gov/41838988/
#ARTNetPublication #SCLC #LungCancer #CancerResearch #RadiationOncology #PrecisionOncology
@lcrf.orgAmong those presenting today at the World Conference on Lung Cancer in Seoul, South Korea: LCRF Education + Engagement Committee members Dr. Sydney Barned and Dr. Stephen Liu; and LCRF research partner, ALCSI’s Dr. Chi-Fu Jeffrey Yang.
#WCLC26 #LungCancer @stephenvliu.bsky.social
@lcrf.orgAmong those presenting today at #WCLC26 in Seoul, South Korea: LCRF Scientific Advisory Board Members Dr. Christine Bestvina and Dr. Karen Reckamp; LCRF grantee Dr. Xiuning Le; and LCRF Together New York panelist Dr. Balazs Halmos.
#LungCancer @balazshalmos.bsky.social
@btog.bsky.socialSelected key takeaway from our 2026 Annual Conference: How Are We Doing? Results of the BTS Pilot Audit presented by Emma O’Dowd. Full recordings and presentations available to members on our website. #LCSM #lungcancer
@thecancersurvivorsclub.comPrecision medicine continues to change lung cancer care. For some patients with EGFR-mutated lung cancer, targeted treatment after surgery can reduce recurrence risk and improve survival.
@cancers-mdpi.bsky.social🤗We were delighted to meet with our editors in person at #WCLC2026!
Thank you for the insightful conversations and continued support in advancing high-quality research in lung cancer✨
#LungCancer #ThoracicOncology #CancersMDPI
@lcrf.orgWhen Glenna was told she had stage 4 #LungCancer, she wasn’t sure what the future held. Today? She and her husband, Chris, are planning their next milestone anniversary trip. "When I was diagnosed in 2023, I only had two treatment options. Now there are more—but we can’t stop there." LCRF.org/fall26
@megadoctornews.comNew AI Tool Accurately Predicts Lung Cancer Immunotherapy Results #ai #ArtificialIntelligence #cancer #CancerTreatment #immunotherapy #LungCancer https://megadoctornews.com/new-ai-tool-accurately-predicts-lung-cancer-immunotherapy-results/